Aayoung Hong

2.8k citations

11 papers · 1.8k indexed · 2 hit papers · h-index 9

Oncology top 2%
- Cutaneous Melanoma Detection and Management 4
- CAR-T cell therapy research 2
- Cancer Immunotherapy and Biomarkers 2
Molecular Biology top 5%
- Melanoma and MAPK Pathways 9
- Protein Kinase Regulation and GTPase Signaling 3
Computational Theory and Mathematics top 2%
- Computational Drug Discovery Methods 2
Cancer Research top 10%
Immunology top 10%
- Immunotherapy and Immune Responses 2
Pathology and Forensic Medicine
- Cancer Mechanisms and Therapy 1

Co-authors: Roger S. Lo Gatien Moriceau Willy Hugo Antoni Ribas Xiangju Kong Hubing Shi Douglas B. Johnson Jeffrey A. Sosman
Cited by: Oncology Molecular Biology Computational Theory and Mathematics
Journals: Cell (1 paper)Cancer Cell (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)
Partner nations: United States Australia Belgium

In The Last Decade

Aayoung Hong

10 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Aayoung Hong

Since Specialization

Citations

This map shows the geographic impact of Aayoung Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aayoung Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aayoung Hong more than expected).

Fields of papers citing papers by Aayoung Hong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aayoung Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aayoung Hong. The network helps show where Aayoung Hong may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Aayoung Hong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aayoung Hong Line = papers co-authored together Aayoung Hong links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work
1	Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma Cancer Discovery ·Prashanthi Dharanipragada,Xiao Zhang,Sixue Liu,Shirley H. Lomeli,Aayoung Hong,Yan Wang,Zhentao Yang,Kara Z. Lo,Agustin Vega-Crespo,Antoni Ribas,Stergios J. Moschos,Gatien Moriceau,Roger S. Lo	2023	53
2	Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma Cell Reports Medicine ·Sixue Liu,Hannah M. Knochelmann,Shirley H. Lomeli,Aayoung Hong,Mary S. Richardson,Zhentao Yang,Raymond J. Lim,Yan Wang,Camelia Dumitras,Kostyantyn Krysan,Cynthia Timmers,Martin J. Romeo,Carsten Krieg,Elizabeth C. O’Quinn,Joshua D. Horton,Steve Dubinett,Chrystal M. Paulos,David M. Neskey,Roger S. Lo	2021	31
3	Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant Melanoma UNC Libraries ·Willy Hugo,Gatien Moriceau,Robert Damoiseaux,Roger S. Lo,Lu Sun,Aayoung Hong,Sheri L. Holmen,Shirley H. Lomeli,Norman E. Sharpless,Marco Piva	2020	0
4	Recurrent Tumor Cell–Intrinsic and –Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation Cancer Discovery ·Chunying Song,Marco Piva,Lu Sun,Aayoung Hong,Gatien Moriceau,Xiangju Kong,Hong Zhang,Shirley H. Lomeli,Jin Qian,Clarissa C. Yu,Robert Damoiseaux,Mark C. Kelley,Kimberley B. Dahlman,Philip O. Scumpia,Jeffrey A. Sosman,Douglas B. Johnson,Antoni Ribas,Willy Hugo,Roger S. Lo	2017	109
5	Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant Melanoma Cancer Discovery ·Aayoung Hong,Gatien Moriceau,Lu Sun,Shirley H. Lomeli,Marco Piva,Robert Damoiseaux,Sheri L. Holmen,Norman E. Sharpless,Willy Hugo,Roger S. Lo	2017	72
6	JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma Cell Discovery ·Bjoern Titz,Anastasia Lomova,Allison Le,Willy Hugo,Xiangju Kong,Johanna ten Hoeve,Michael Friedman,Hubing Shi,Gatien Moriceau,Chunying Song,Aayoung Hong,Mohammad Atefi,Richard Li,Evangelia Komisopoulou,Antoni Ribas,Roger S. Lo,Thomas G. Graeber	2016	43
7	Tunable-Combinatorial Mechanisms of Acquired Resistance Limit the Efficacy of BRAF/MEK Cotargeting but Result in Melanoma Drug Addiction Cancer Cell ·Gatien Moriceau,Willy Hugo,Aayoung Hong,Hubing Shi,Xiangju Kong,Clarissa C. Yu,Richard C. Koya,Ahmed A. Samatar,Négar Khanlou,Jonathan Braun,Kathleen Ruchalski,Heike Seifert,James Larkin,Kimberly B. Dahlman,Douglas B. Johnson,Alain P. Algazi,Jeffrey A. Sosman,Antoni Ribas,Roger S. Lo	2015	237
8	Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistancebreakdown → Cell ·Willy Hugo,Hubing Shi,Lu Sun,Marco Piva,Chunying Song,Xiangju Kong,Gatien Moriceau,Aayoung Hong,Kimberly B. Dahlman,Douglas B. Johnson,Jeffrey A. Sosman,Antoni Ribas,Roger S. Lo	2015	412
9	Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapybreakdown → Cancer Discovery ·Hubing Shi,Willy Hugo,Xiangju Kong,Aayoung Hong,Richard C. Koya,Gatien Moriceau,Thinle Chodon,Rongqing Guo,Douglas B. Johnson,Kimberly B. Dahlman,Mark C. Kelley,Richard Kefford,Bartosz Chmielowski,John A. Glaspy,Jeffrey A. Sosman,Nicolas van Baren,Georgina V. Long,Antoni Ribas,Roger S. Lo	2013	715
10	A Novel AKT1 Mutant Amplifies an Adaptive Melanoma Response to BRAF Inhibition Cancer Discovery ·Hubing Shi,Aayoung Hong,Xiangju Kong,Richard C. Koya,Chunying Song,Gatien Moriceau,Willy Hugo,Clarissa C. Yu,Charles Ng,Thinle Chodon,Richard A. Scolyer,Richard Kefford,Antoni Ribas,Georgina V. Long,Roger S. Lo	2013	133
11	Adjuvant Radiotherapy Improves Regional (Lymph Node Field) Control in Melanoma Patients after Lymphadenectomy International Journal of Radiation OncologyBiologyPhysics ·B. Burmeister,M. Henderson,John F. Thompson,R I Fisher,Juliana Di Iulio,B. Mark Smithers,Aayoung Hong,Scott Carruthers,Harald Hoekstra,Jill Ainslie	2009	1

About Aayoung Hong

Aayoung Hong is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 11 papers that have together received 1.8k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (9 papers), Cutaneous Melanoma Detection and Management (4 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), CAR-T cell therapy research (2 papers), Immunotherapy and Immune Responses (2 papers), Computational Drug Discovery Methods (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Oncology (1.0k citations), Molecular Biology (1.5k citations) and Computational Theory and Mathematics (273 citations). Aayoung Hong has collaborated with scholars based in United States, Australia and Belgium. Frequent co-authors include Roger S. Lo, Gatien Moriceau, Willy Hugo, Antoni Ribas, Xiangju Kong, Hubing Shi, Douglas B. Johnson, Jeffrey A. Sosman, Kimberly B. Dahlman and Richard C. Koya. Their work appears in journals such as Cell, Cancer Cell and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact